Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ConfometRx

- PMLiVE

UCB’s Steve Arnold joins ABPI board

Will work to support life sciences in the UK

- PMLiVE

UCB files Vimpat patent claims against 15 companies

Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug

China flag thumb

AstraZeneca and UCB drawn into Chinese investigations

Follows country’s clampdown on GSK bribery

UCB and IBM to harness big data for personalised epilepsy care

Joint project could pave the way for therapy area use of IBM's Watson

- PMLiVE

Steve Arnold joins UCB from Gilead

Appointed managing director for the British and Irish Isles

- PMLiVE

UCB CEO: Patient info more important than transparency

Roch Doliveux says misinformation is the “worst thing that can happen in healthcare”

- PMLiVE

UCB says new medicines drive growth in 2012

Also optimistic about its late-stage pipeline

- PMLiVE

UCB signs research deal for novel neuroscience drugs

Partners with structural biology company ConfometRx

- PMLiVE

UCB-Amgen pull development of drug to heal fractures

But romosozumab remains on course in postmenopausal osteoporosis

EU funds ‘human brain’ computing project

Project could ultimately help develop personalised neurological treatments

UCB launches arthritis exercise programme in the UK

Scheme was piloted at two NHS Trusts during 2011

- PMLiVE

Eliquis and Ryzodeg feature among Japan’s year-end approvals

Actonel and Neupro also given green light

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links